Jazz Pharmaceuticals PLC (JAZZ)

Jazz Pharmaceuticals PLC (JAZZ) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $13.9B; returns 1 day -0.3%, 1 week +1.8%, 1 year +54.9%.

Jazz Pharmaceuticals PLC is a global biopharmaceutical company primarily focused on developing and commercializing innovative medicines for serious diseases with high unmet needs, predominantly within neuroscience (sleep disorders and epilepsy) and oncology.

Groups JAZZ belongs to

• Healthcare
• Biotechnology
• Biopharmaceutical
• Pharmaceuticals
• Neuroscience
• Oncology
• Rare Diseases
• Commercial Stage
• Epilepsy
• Cannabis

JAZZ financial model: income statement, cash flow and balance sheet